GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 76 filers reported holding GAMIDA CELL LTD in Q1 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,279 | -91.7% | 10,950 | -89.6% | 0.00% | – |
Q4 2022 | $135,932 | -25.3% | 105,374 | -8.0% | 0.00% | – |
Q3 2022 | $182,000 | +2.8% | 114,569 | +14.3% | 0.00% | – |
Q2 2022 | $177,000 | -30.9% | 100,264 | 0.0% | 0.00% | – |
Q1 2022 | $256,000 | +0.4% | 100,264 | 0.0% | 0.00% | – |
Q4 2021 | $255,000 | -44.2% | 100,264 | -14.0% | 0.00% | – |
Q3 2021 | $457,000 | -38.8% | 116,595 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $747,000 | -24.5% | 116,595 | -4.7% | 0.00% | 0.0% |
Q1 2021 | $990,000 | -8.2% | 122,349 | -4.9% | 0.00% | 0.0% |
Q4 2020 | $1,079,000 | +88.6% | 128,620 | -6.6% | 0.00% | 0.0% |
Q3 2020 | $572,000 | -36.1% | 137,729 | -29.7% | 0.00% | 0.0% |
Q2 2020 | $895,000 | +14816.7% | 195,786 | +9689.3% | 0.00% | – |
Q1 2020 | $6,000 | +50.0% | 2,000 | +100.0% | 0.00% | – |
Q4 2019 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -54.5% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | +10.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,287,745 | $27,584,000 | 2.58% |
Stonepine Capital Management, LLC | 379,470 | $3,184,000 | 2.44% |
Healthcare Value Capital, LLC | 50,000 | $420,000 | 1.42% |
BVF INC/IL | 1,343,667 | $11,273,000 | 0.44% |
Rock Springs Capital Management LP | 2,094,000 | $17,569,000 | 0.37% |
SILVERARC CAPITAL MANAGEMENT, LLC | 70,852 | $594,000 | 0.34% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,431,795 | $20,403,000 | 0.33% |
Atom Investors LP | 217,231 | $1,823,000 | 0.18% |
MYDA Advisors LLC | 56,000 | $470,000 | 0.14% |
J. Goldman & Co LP | 314,236 | $2,636,000 | 0.13% |